WallStreetZenWallStreetZen

NYSE: ABT
Abbott Laboratories Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Abbott Laboratories revenue was $41.22B for the trailing 12 months ending Sep 30, 2024, with 11.9% growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $10.6B, up 2.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ABT annual revenue was $40.1B, with -8.1% growth year-over-year.

ABT past revenue growth

How has ABT's revenue growth performed historically?

Company
3.15%
Industry
11.31%
Market
34.47%
ABT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ABT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ABT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ABT revenue history

Current Revenue
$41.2B
Current Earnings
$5.8B
Current Profit Margin
14%
ABT's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when ABT announces revenue.

ABT Revenue History By Year

ABT Yearly RevenueABT RevenueABT ChangeABT Revenue Growth
2023-12-31$40.11B-$3.54B-8.12%
2022-12-31$43.65B$578.00M+1.34%
2021-12-31$43.08B$8.47B+24.47%
2020-12-31$34.61B$2.70B+8.48%
2019-12-31$31.90B$1.33B+4.34%
2018-12-31$30.58B$3.19B+11.64%
2017-12-31$27.39B$6.54B+31.35%
2016-12-31$20.85B$448.00M+2.20%
2015-12-31$20.41B$158.00M+0.78%
2014-12-31$20.25B$590.00M+3.00%
2013-12-31$19.66B$607.00M+3.19%
2012-12-31$19.05B-$2.36B-11.01%
2011-12-31$21.41B-$13.76B-39.13%
2010-12-31$35.17B$4.40B+14.31%
2009-12-31$30.76B$1.24B+4.19%
2008-12-31$29.53B$3.61B+13.94%
2007-12-31$25.91B$3.44B+15.30%
2006-12-31$22.48B$138.51M+0.62%
2005-12-31$22.34B$2.66B+13.51%
2004-12-31$19.68B$2.40B+13.89%
2003-12-31$17.28B$2.00B+13.09%
2002-12-31$15.28B-$1.01B-6.18%
2001-12-31$16.29B$2.54B+18.47%
2000-12-31$13.75B$568.29M+4.31%
1999-12-31$13.18B$664.89M+5.31%
1998-12-31$12.51B$623.45M+5.24%
1997-12-31$11.89B$875.82M+7.95%
1996-12-31$11.01B$1.00B+10.00%
1995-12-31$10.01B$856.19M+9.35%
1994-12-31$9.16BN/AN/A

1 of 2

Abbott Laboratories Revenue FAQ

What was ABT's revenue last quarter?

On Invalid Date, Abbott Laboratories (NYSE: ABT) reported Q3 2024 revenue of $10.64 billion up 4.85% year over year. In the same quarter last year, Abbott Laboratories's revenue was $10.14 billion.

What was Abbott Laboratories's revenue in 2023?

Abbott Laboratories's annual revenue for the twelve months ending Dec 31, 2023 was $40.11 billion, a 8.12% decrease year over year.

How much does Abbott Laboratories make in a day?

Based on Abbott Laboratories annual revenue for the past five years, ABT makes an average of $105,944,657.53 per day.

What was Abbott Laboratories's annual revenue growth in the past year?

As of Q1 2025, Abbott Laboratories's revenue has grown 3.15% year over year. This is 8.16 percentage points lower than the US Medical Devices industry revenue growth rate of 11.31%. Abbott Laboratories's revenue in the past year totaled $41.22 billion.

How much does Abbott Laboratories make in a year?

Abbott Laboratories's revenue by year for the past five years is:
  • Abbott Laboratories's revenue for the twelve months ending Dec 31, 2023 was $40.11 billion, a 8.12% decrease year over year.
  • Abbott Laboratories's annual revenue for Dec 31, 2022 was $43.65 billion, a 1.34% increase from 2021.
  • Abbott Laboratories's annual revenue for 2021 was $43.08 billion, a 24.47% increase from 2020.
  • Abbott Laboratories's annual revenue for 2020 was $34.61 billion, a 8.48% increase from 2019.
  • Abbott Laboratories's annual revenue for 2019 was $31.90 billion, a 4.34% increase from 2018.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.